Skip to main content
. Author manuscript; available in PMC: 2017 Jul 10.
Published in final edited form as: Bioconjug Chem. 2016 Jul 27;27(8):1830–1838. doi: 10.1021/acs.bioconjchem.6b00241

Figure 6.

Figure 6

Viability of BxPC-3 cells cultured as monolayers (A) and three-dimensional spheroids (B) after treatment with DSPC LNs encapsulating gemcitabine (20 µM), free gemcitabine (20 µM), gemcitabine encapsulated hypoxia-responsive LNs devoid of surface iRGD peptide, and the hypoxia-sensitive LNs with the iRGD under normoxic (red bars) and hypoxic conditions (green bars).